Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:ibandronate
|
| gptkbp:approvalYear |
2003
|
| gptkbp:ATCCode |
M05BA06
|
| gptkbp:CASNumber |
114084-78-5
|
| gptkbp:chemicalFormula |
C9H23NO7P2
|
| gptkbp:contraindication |
hypocalcemia
|
| gptkbp:drugClass |
bisphosphonate
|
| gptkbp:eliminationHalfLife |
10-60 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Boniva
|
| gptkbp:indication |
prevention of postmenopausal osteoporosis
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Roche
GlaxoSmithKline |
| gptkbp:mechanismOfAction |
inhibits osteoclast-mediated bone resorption
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
muscle pain
gastrointestinal upset flu-like symptoms |
| gptkbp:synonym |
gptkb:ibandronic_acid
|
| gptkbp:usedFor |
gptkb:bone
|
| gptkbp:bfsParent |
gptkb:ibandronate
gptkb:ibandronic_acid gptkb:Bonviva |
| gptkbp:bfsLayer |
7
|